Latham & Watkins’ hot year in 2018 was marked by a series of wins for clients in cases where policy met the law, including a high-stakes challenge to a compelled warning label in California and an orphan-drug exclusivity case that firm leaders said brought a regulatory agency back into compliance with federal statute.
The results, though impressive, were hardly surprising for a firm that boasts a deep bench of former government attorneys and prides itself on team spirit and working across geographic lines.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]